Jan 21, 2021 | Drug & Alcohol Testing News
The Canadian R&D company Entheon Biomedical has set out to investigate the therapeutic use of the psychedelic dimethyltryptamine (DMT) in treating addiction disorders. Specifically, the company has commissioned a clinical trial investigating the safety and...
Jan 19, 2021 | Drug & Alcohol Testing News
A recent report created by Nova Scotia’s provincial health department to evaluate which illicit drugs are impacting communities across the province has been kept confidential by the government and has not been made available to the general public. The report, compiled...
Jan 14, 2021 | Drug & Alcohol Testing News
Following Vancouver City Council’s unanimous vote for drug decriminalization earlier in December, Yellowknife North MLA Rylund Johnson and Kamloops city council have also been pushing for decriminalization of illicit drugs. In response to a news article on Twitter,...
Jan 12, 2021 | Drug & Alcohol Testing News
According to the results of a new study, people who visit the emergency room at least twice in 12 months due to alcohol-related reasons are more likely to die within one year. The study, conducted in Ontario by researchers at International Credential Evaluation...
Jan 8, 2021 | Drug & Alcohol Testing News
According to the results of a new research study, CBD low-dose does not impair driving, while consuming moderate amounts of THC results in mild to strong, short-lived impairment, lasting up to four hours. The results of the study, led by researchers the Lambert...
Dec 29, 2020 | Drug & Alcohol Testing News
Earlier in November, Numinus Wellness Inc., announced that it is planning a compassionate access clinical trial of psilocybin-assisted psychotherapy for substance use disorders. Numinus, originally created as a cannabis technology company, has also focused on the...
